ABT (STOCKS)
Abbott Laboratories
$88.449400
-0.050600 (-0.06%)
Prev close: $88.500000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Robert B. Ford
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $153,950.09M
- Employees
- 114,000
- P/E (TTM)
- 24.66
- P/B (TTM)
- 2.96
- Dividend Yield
- 275.71%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
10
Strong Buy
14
Buy
10
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$1.15 | $1.16 | -0.0052 | -0.45% |
|
Dec 2025 (Q4)
|
$1.50 | $1.51 | -0.0113 | -0.75% |
|
Sep 2025 (Q3)
|
$1.30 | $1.31 | -0.0139 | -1.06% |
|
Jun 2025 (Q2)
|
$1.26 | $1.27 | -0.0074 | -0.58% |
Financial Statements
| Revenues | $45.13B |
| Benefits Costs and Expenses | $37.00B |
| Cost Of Revenue | $19.74B |
| Costs And Expenses | $37.43B |
| Gross Profit | $25.39B |
| Operating Expenses | $17.69B |
| Selling, General, and Administrative Expenses | $13.01B |
| Research and Development | $2.99B |
| Other Operating Expenses | $1.68B |
| Operating Income/Loss | $7.71B |
| Income/Loss From Continuing Operations After Tax | $6.28B |
| Income/Loss From Continuing Operations Before Tax | $8.14B |
| Income Tax Expense/Benefit | $1.86B |
| Net Income/Loss | $6.28B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $6.28B |
| Net Income/Loss Available To Common Stockholders, Basic | $6.30B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$24.00M |
| Preferred Stock Dividends And Other Adjustments | -$24.00M |
| Basic Earnings Per Share | $3.59 |
| Diluted Earnings Per Share | $3.57 |
| Basic Average Shares | 3,485,569,000 |
| Diluted Average Shares | 3,496,854,000 |
| Assets | $110.43B |
| Current Assets | $25.51B |
| Inventory | $6.99B |
| Other Current Assets | $18.52B |
| Noncurrent Assets | $84.92B |
| Fixed Assets | $12.38B |
| Intangible Assets | $17.88B |
| Other Non-current Assets | $54.67B |
| Liabilities | $57.73B |
| Current Liabilities | $18.38B |
| Wages | $1.21B |
| Other Current Liabilities | $17.17B |
| Noncurrent Liabilities | $39.35B |
| Equity | $52.70B |
| Equity Attributable To Noncontrolling Interest | $640.00M |
| Equity Attributable To Parent | $52.06B |
| Liabilities And Equity | $110.43B |
| Net Cash Flow From Operating Activities | $9.46B |
| Net Cash Flow From Operating Activities, Continuing | $9.46B |
| Net Cash Flow From Investing Activities | -$22.28B |
| Net Cash Flow From Investing Activities, Continuing | -$22.28B |
| Net Cash Flow From Financing Activities | $13.06B |
| Net Cash Flow From Financing Activities, Continuing | $13.06B |
| Net Cash Flow | $247.00M |
| Net Cash Flow, Continuing | $247.00M |
| Comprehensive Income/Loss | $7.38B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $7.38B |
| Other Comprehensive Income/Loss | $7.38B |
| Other Comprehensive Income/Loss Attributable To Parent | $1.11B |